Home

AbbVie (ABBV)

223.35
+0.36 (0.16%)
NYSE · Last Trade: Dec 10th, 2:02 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Guardian Wealth Takes $5.1 Million Stake in Viper Energy, According to Recent SEC Filingfool.com
Guardian Wealth bought over 133,000 shares of Viper Energy during the third quarter of 2025.
Via The Motley Fool · December 10, 2025
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index largely treaded water, the healthcare segment registered a notable decline of 0.5%, extending a three-day
Via MarketMinute · December 9, 2025
1 Major Factor Behind the Healthcare Sector's Recent Surgefool.com
Blockbuster drugs are a major driver of the growth of healthcare stocks.
Via The Motley Fool · December 9, 2025
3 Top Dividend Stocks to Buy in Decemberfool.com
Great dividends are only part of the attraction with these stocks.
Via The Motley Fool · December 9, 2025
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.fool.com
This drugmaker has a strong portfolio of best-selling drugs and a growing pipeline.
Via The Motley Fool · December 6, 2025
Could Buying AbbVie Today Set You Up for Life?fool.com
Don't bet against it.
Via The Motley Fool · December 4, 2025
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026fool.com
These ETFs can provide me with lots of passive income.
Via The Motley Fool · December 4, 2025
Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny
New York, NY – December 3, 2025 – In a significant move reverberating through the biotechnology sector, investment banking giant Morgan Stanley has downgraded Regeneron Pharmaceuticals (NASDAQ: REGN) from "Overweight" to "Equal-Weight." The firm maintained its price target of $767.00, signaling that, in their view, the stock is now fairly valued
Via MarketMinute · December 3, 2025
2 Top Dividend Stocks to Buy Now and Hold For a Decadefool.com
These healthcare leaders can make you money while you sleep.
Via The Motley Fool · December 2, 2025
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Yearsfool.com
These stocks have been raising their dividend payments annually for well over a decade, and they pay more than twice the S&P 500 average.
Via The Motley Fool · November 29, 2025
8 Dividend Stocks Every Investor Should Considerfool.com
From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.
Via The Motley Fool · November 28, 2025
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Fearedstocktwits.com
Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries.
Via Stocktwits · November 27, 2025
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · November 26, 2025
1 Surging Stock with Exciting Potential and 2 Facing Challenges
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via StockStory · November 25, 2025
5 Dividend Stocks to Hold for the Next 10 Yearsfool.com
Investors should be able to count on steady dividends from these great stocks.
Via The Motley Fool · November 24, 2025
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Via StockStory · November 21, 2025
Unpacking the Latest Options Trading Trends in AbbViebenzinga.com
Via Benzinga · November 20, 2025
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?marketbeat.com
Via MarketBeat · November 19, 2025
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · November 19, 2025
Healthcare Rotation Underway: 3 Stocks Leading the Chargemarketbeat.com
Via MarketBeat · November 19, 2025
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · November 19, 2025
A Look Into AbbVie Inc's Price Over Earningsbenzinga.com
Via Benzinga · November 17, 2025
AbbVie Stock Falls 4% -- What Investors Need to Knowfool.com
It's no reason to stay up at night.
Via The Motley Fool · November 17, 2025
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?fool.com
Healthcare stocks have far outperformed the broader market over the past month.
Via The Motley Fool · November 17, 2025
These 2 Dividend ETFs Are a Retiree's Best Friendfool.com
Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.
Via The Motley Fool · November 16, 2025